Events Calendar

Mon
Tue
Wed
Thu
Fri
Sat
Sun
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
12:00 AM - DEVICE TALKS
9
11
12
13
14
16
18
19
20
21
22
23
24
26
27
28
29
30
31
1
2
3
4
DEVICE TALKS
DEVICE TALKS BOSTON 2018: BIGGER AND BETTER THAN EVER! Join us Oct. 8-10 for the 7th annual DeviceTalks Boston, back in the city where it [...]
6th Annual HealthIMPACT Midwest
2018-10-10    
All Day
REV1 VENTURES COLUMBUS, OH The Provider-Patient Experience Summit - Disrupting Delivery without Disrupting Care HealthIMPACT Midwest is focused on technologies impacting clinician satisfaction and performance. [...]
15 Oct
2018-10-15 - 2018-10-16    
All Day
Conference Series Ltd invites all the participants from all over the world to attend “3rd International Conference on Environmental Health” during October 15-16, 2018 in Warsaw, Poland which includes prompt keynote [...]
17 Oct
2018-10-17 - 2018-10-19    
7:00 am - 6:00 pm
BALANCING TECHNOLOGY AND THE HUMAN ELEMENT In an era when digital technologies enable individuals to track health statistics such as daily activity and vital signs, [...]
Epigenetics Congress 2018
2018-10-25 - 2018-10-26    
All Day
Conference: 5th World Congress on Epigenetics and Chromosome Date: October 25-26, 2018 Place: Istanbul, Turkey Email: epigeneticscongress@gmail.com About Conference: Epigenetics congress 2018 invites all the [...]
Events on 2018-10-08
DEVICE TALKS
8 Oct 18
425 Summer Street
Events on 2018-10-10
Events on 2018-10-17
17 Oct
Events on 2018-10-25
Epigenetics Congress 2018
25 Oct 18
Istanbul
Latest News

UK government releases details of COVID-19 data-sharing deals with big tech firms after legal action threat

healthcare

Contracts released by the UK government have revealed that personal health information about millions of NHS patients was provided to private tech firms involved in the COVID-19 datastore project. The project announced in March intended to collate data from health and social care organisations in order to “provide a single source of truth” about the pandemic.

However there were concerns about privacy issues, with MPs asking questions in parliament about the deals with private firms and more than 13,000 people joining a call for transparency.  Political website openDemocracy and tech justice firm Foxglove sent legal letters demanding transparency about the agreements, which were revealed hours before court proceedings were due to start on 5 June. Details of the deals with Google, Amazon, Microsoft and Palantir and Faculty have been published online by openDemocracy.

They reveal that companies involved in the datastore project were originally granted intellectual property rights and allowed to train their models and profit from access to NHS data, but the terms of the deal were changed after a Freedom of Information request made by Foxglove.

The Faculty contract shows that the firm, which has been linked to Dominic Cummings – the Prime Minister’s chief adviser, is being paid more than £1 million to provide artificial intelligence (AI) services for the NHS.

WHY IT MATTERS 

An NHS blog announcing the datastore project, had ensured privacy, stating that  “essential data governance procedures and established principles of openness and transparency remain at the core of everything we do”; that the data collected “will only be used for COVID-19”; and that “only relevant information will be collected.”

It also said that “once the public health emergency situation has ended, data will either be destroyed or returned in line with the law and the strict contractual agreements that are in place between the NHS and partners”.

THE LARGER CONTEXT 

Campaigning organisations, Privacy International and the Open Rights Group previously issued a statement raising concerns about the involvement of Palantir, flagging up the firm’s past work on the tracking of migrants and provision of espionage tools.

ON THE RECORD

Foxglove founding director Cori Crider and openDemocracy editor-in-chief Mary Fitzgerald wrote in a blog post: “The contracts show that the companies involved, including Faculty and Palantir, were originally granted intellectual property rights (including the creation of databases), and were allowed to train their models and profit off their unprecedented access to NHS data.”

A Faculty spokesperson said the company “asked for its contract to be amended to make clear that it will derive no commercial benefit from any software, including trained machine learning models, developed during the course of the project and that the use of the IP is under the sole control of the NHS”.